I think GiveWell has considered funding RCTs for promising interventions and decided against it. They easily cost millions of dollars, take several years, and the evidence provided is often quite weak. Best to focus on the existing evidence-base from academia first, then move on to new RCTs when that’s all exhausted (ideally through partnerships with academics, which I think is what DMI did).
I think GiveWell has considered funding RCTs for promising interventions and decided against it. They easily cost millions of dollars, take several years, and the evidence provided is often quite weak. Best to focus on the existing evidence-base from academia first, then move on to new RCTs when that’s all exhausted (ideally through partnerships with academics, which I think is what DMI did).